Article Versions Notes

Bertani L, Caviglia GP, Antonioli L, Pellicano R, Fagoonee S, Astegiano M, Saracco GM, Bugianesi E, Blandizzi C, Costa F, et al. Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine. 2020; 9(5):1323. https://doi.org/10.3390/jcm9051323

Bertani, Lorenzo, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa, and et al. 2020. "Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases" Journal of Clinical Medicine 9, no. 5: 1323. https://doi.org/10.3390/jcm9051323

Bertani, L., Caviglia, G. P., Antonioli, L., Pellicano, R., Fagoonee, S., Astegiano, M., Saracco, G. M., Bugianesi, E., Blandizzi, C., Costa, F., & Ribaldone, D. G. (2020). Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine, 9(5), 1323. https://doi.org/10.3390/jcm9051323